We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFAC
201
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$2.88M 0.07%
280,601
+198,204
+241% +$2.01M
KYCH
202
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
$2.86M 0.07%
283,133
+38,354
+16% +$384K
GTI
203
DELISTED
Graphjet Technology
GTI
$2.85M 0.07%
4,606
-12,529
-73% -$7.71M
ADRT
204
DELISTED
Ault Disruptive Technologies Corporation
ADRT
$2.83M 0.07%
276,038
-64,408
-19% -$653K
HORI
205
DELISTED
Emerging Markets Horizon Corp. Class A Ordinary Shares
HORI
$2.83M 0.07%
276,971
+158,141
+133% +$1.6M
CSLM
206
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$2.76M 0.07%
272,493
-55
-0% -$551
DRAY
207
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$2.7M 0.07%
264,756
+197,544
+294% +$1.99M
DNAD
208
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.67M 0.07%
265,573
-9,181
-3% -$91.2K
CDAQ
209
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$2.63M 0.07%
+262,402
New +$2.59M
TRIS
210
DELISTED
Tristar Acquisition I Corp.
TRIS
$2.61M 0.07%
+257,750
New +$2.59M
AIRJ
211
Montana Technologies Corp
AIRJ
$318M
$2.54M 0.07%
252,617
+63,366
+33% +$631K
HSPOU
212
DELISTED
Horizon Space Acquisition I Corp Unit
HSPOU
$2.52M 0.07%
+250,000
New +$2.52M
ENTF
213
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
$2.52M 0.07%
244,714
+12,451
+5% +$127K
KCGI
214
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$2.5M 0.06%
245,482
+189,083
+335% +$1.91M
DNAB
215
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$2.44M 0.06%
242,413
+49,597
+26% +$493K
XBP icon
216
XBP Global Holdings
XBP
$36.2M
$2.4M 0.06%
+23,042
New +$2.38M
BFAC
217
DELISTED
Battery Future Acquisition Corp.
BFAC
$2.33M 0.06%
227,049
+92,290
+68% +$937K
AEON icon
218
AEON Biopharma
AEON
$11.3M
$2.32M 0.06%
3,207
+71
+2% +$50.9K
LIVB
219
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
$2.27M 0.06%
220,766
+149,871
+211% +$1.53M
AOGO
220
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$2.24M 0.06%
221,437
+87,715
+66% +$877K
KACL
221
DELISTED
Kairous Acquisition Corp. Limited Ordinary Shares
KACL
$2.22M 0.06%
215,000
-539,573
-72% -$5.5M
EONR
222
EON Resources
EONR
$24.7M
$2.22M 0.06%
216,671
+57,171
+36% +$579K
SGII
223
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$2.2M 0.06%
216,150
+100,069
+86% +$1.01M
AQU
224
DELISTED
Aquaron Acquisition Corp. Common Stock
AQU
$2.18M 0.06%
+217,131
New +$2.17M
MMV
225
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
$2.12M 0.05%
201,515
+40,154
+25% +$417K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.